CareLit · DOI-Nachweis · Aktuelle Urologie
Progress in the Management of Advanced Renal Cell Carcinoma (RCC)
DOI 10.1055/s-0030-1247237
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT. Q. T. Tong, D. Rohde, S. Peter
ZeitschriftAktuelle Urologie
AusgabeS 01/2010
Jahrgang / SeitenJg. 41 · S. S57-S60
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract A more profound understanding in the pathophysiological mechanism of renal cell cancer has led to a shift in the treatment approach. Traditionally, cytokines were the frontline drugs, but recently this has transitioned to drugs interacting vascular endothelial growth factor (VEGF) related pathway. Sorafenib, sunitinib, bevacizumab, temsirolimus and everolimus have demonstrated clinical improvements in rando…
Zitieren
Zitierempfehlung
T. Q. T. Tong, D. Rohde, S. Peter (2010) Progress in the Management of Advanced Renal Cell Carcinoma (RCC). Aktuelle Urologie, 41 (S 01), S57-S60. https://doi.org/10.1055/s-0030-1247237
Mit CareLit weiterarbeiten